**Figure 2.** Fig 1. PRISMA flow diagram of evaluated studies for randomized controlled trials for efficacy of specific probiotics for the prevention or treatment of various diseases, searched from inception of databases to June 2018. Outcomes were extracted from randomized controlled trials (RCT) with a primary outcome and may have included additional secondary outcomes and/or additional treatment arms per trial.

Description

A PRISMA flow diagram details the systematic literature search and study selection process for evaluating probiotic efficacy across multiple clinical conditions. Studies are screened from inception through defined databases with specific inclusion and exclusion criteria.

More Figures from This Paper

Figure 3

A clinical decision algorithm guides clinicians through the process of selecting an appropriate probiotic product based on the patient's specific condition, available evidence for particular strains, and practical considerations such as product availability and cost.

flowchart

Figure 2

Flowchart

684 × 654px · 148,0 Kio

Source Paper

Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.

PloS one (2018)

PMID: 30586435

DOI: 10.1371/journal.pone.0209205

Cite This Figure

![Figure 2: A PRISMA flow diagram details the systematic literature search and study selection process for evaluating probiotic efficacy across multiple clinical conditions. Studies are screened from inception through defined databases with specific inclusion and exclusion criteria.](https://pdfs.citedhealth.com/figures/30586435/394.png)

> Source: Jason C Sniffen et al. "Choosing an appropriate probiotic product for your patient: An evidence-based pr." *PloS one*, 2018. PMID: [30586435](https://pubmed.ncbi.nlm.nih.gov/30586435/)

<figure>
  <img src="https://pdfs.citedhealth.com/figures/30586435/394.png" alt="A PRISMA flow diagram details the systematic literature search and study selection process for evaluating probiotic efficacy across multiple clinical conditions. Studies are screened from inception through defined databases with specific inclusion and exclusion criteria." />
  <figcaption>Figure 2. A PRISMA flow diagram details the systematic literature search and study selection process for evaluating probiotic efficacy across multiple clinical conditions. Studies are screened from inception through defined databases with specific inclusion and exclusion criteria.<br>  Source: Jason C Sniffen et al. "Choosing an appropriate probiotic product for your patient: An evidence-based pr." <em>PloS one</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30586435/">30586435</a></figcaption>
</figure>

Preuves associées

Saccharomyces boulardii pour Antibiotic-Associated Diarrhea (AAD)

Note A · 25 études

Saccharomyces boulardii pour Traveler's Diarrhea

Note B · 4 études